Zacks Investment Research on MSN5d
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback